Scientific publications

Neurology Neuroimmunology & Neuroinflammation, 2024

Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion

Gawde S., Siebert N., Ruprecht K. et al.

Brain, Behavior, and Immunity, 2024

Plasma IL-6 levels and their association with brain health and dementia risk: A population-based cohort study

Zhao Z., Zhang J., Wu Y. et al.

Metabolites, 2024

Intra-Individual Variations in How Insulin Sensitivity Responds to Long-Term Exercise: Predictions by Machine Learning Based on Large-Scale Serum Proteomics

Viken J., Olsen T., Drevon C. et al.

Nature Medicine, 2024

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

Horwitz S., Nirmal A., Rahman J. et al.

Brain, Behavior, and Immunity, 2024

Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, “basket” trial

Arteaga-Henríquez G., Ramos-Sayalero C., Ibañez-Jimenez P. et al.

Inflammation, 2024

Comparative Proteomics Analysis Reveals Distinct Molecular Phenotype and Biomarkers in Patients with Erythrodermic Atopic Dermatitis and Erythrodermic Psoriasis

Song B., Ning X., Guo L. et al.

Journal of the American Heart Association, 2024

Prognostic Significance of Proteomics‐Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension

Yokokawa T., Boucherat O., Martineau S. et al.

Journal of the American Heart Association, 2024

Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition

Kraaijenhof J., Cronjé H., Hovingh G. et al.

Diabetes/Metabolism Research and Reviews, 2024

Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study

Herder C., Thorand B., Strom A. et al.

Psychoneuroendocrinology, 2024

Associations between sickness behavior, but not inflammatory cytokines, and psychiatric comorbidity in chronic pain

Åström Reitan J., Karshikoff B., Holmström L. et al.

Thorax, 2024

Genetic-informed proteome-wide scan reveals potential causal plasma proteins for idiopathic pulmonary fibrosis

Zhu J., Liu H., Gao R. et al.

Brain Communications, 2024

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing

Tan I., Modderman R., Stachurska A. et al.

JAMA Cardiology, 2024

Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension

Rao P., Keyes M., Mi M. et al.

American Journal of Human Biology, 2024

Targeted proteomics involved in cardiovascular health and heart rate variability in children with overweight/obesity

Plaza‐Florido A., Olvera‐Rojas M., Alcantara J. et al.

Immunity & Ageing, 2024

Immune cell phenotypes and mortality in the Framingham Heart Study

Ragab A., Doyle M., Chen J. et al.

Neurology, 2024

Mechanisms of Hypercoagulability Driving Stroke Risk in Obesity

Daghlas I., Gill D.

Frontiers in Immunology, 2024

Genetic association of the gut microbiota with epigenetic clocks mediated by inflammatory cytokines: a Mendelian randomization analysis

Tian S., Liao X., Chen S. et al.

International Journal of Cancer, 2024

Pre‐diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population‐based cohort studies from the United States and the United Kingdom

Zhao L., Zhang X., Birmann B. et al.

International Journal of Molecular Sciences, 2024

Immature Surfactant Protein B Increases in the Serum of Patients with Calcific Severe Aortic Stenosis

Eligini S., Savini C., Ghilardi S. et al.

Translational Neurodegeneration, 2024

DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease

Appleton E., Khosousi S., Ta M. et al.